Logo-npj
ePublished: 01 Jan 2015
EndNote EndNote

(Enw Format - Win & Mac)

BibTeX BibTeX

(Bib Format - Win & Mac)

Bookends Bookends

(Ris Format - Mac only)

EasyBib EasyBib

(Ris Format - Win & Mac)

Medlars Medlars

(Txt Format - Win & Mac)

Mendeley Web Mendeley Web
Mendeley Mendeley

(Ris Format - Win & Mac)

Papers Papers

(Ris Format - Win & Mac)

ProCite ProCite

(Ris Format - Win & Mac)

Reference Manager Reference Manager

(Ris Format - Win only)

Refworks Refworks

(Refworks Format - Win & Mac)

Zotero Zotero

(Ris Format - Firefox Plugin)

J Nephropharmacol. 2015;4(1): 37-41.
  Abstract View: 9258
  PDF Download: 4156

Review

Does frequent hemodialysis regimen results in regression of left ventricular mass compared to conventional hemodialysis?

Chaudhary Muhammad Junaid Nazar 1*, Faisal Bashir 2, Syed Ahtizaz Ahmed 3, Saba Izhar 4

1 Department of Endocrinology, University of Buckingham, Royal Gwent Hospital, NHS Trust, Wales, UK
2 Department of ENT, New City Teaching Hospital, Mohetarma Benazir Bhutto Shaheed Medical College, Mirpur Azad Kashmir, Pakistan
3 Department of Internal Medicine, Allma Iqbal Memorial Teaching Hospital Sialkot, Punjab, Pakistan
4 Department of Community Medicine, Nawaz Sharif Medical College, Gujarat, Pakistan
*Corresponding Author: *Corresponding author: Chaudhary Muhammad Junaid Nazar, , Email: dr.cmjnazar@live.co.uk

Abstract

Several advances in dialysis therapies have been made. Still, the mortality in end-stage renal disease (ESRD) remains high at rates exceeding 15%. Cardiovascular disease from heart failure or sudden death remains an important cause for mortality in these groups. The most common cardiac anomaly in ESRD is cardiac hypertrophy and this has been observed in 75% of patients at the time of starting dialysis. Also, in patients on conventional hemodialysis (CHD) (4 hours, 3 times per week), left ventricular hypertrophy (LVH) is an independent risk factor for mortality, arrhythmias, heart failure and myocardial ischemia. Stroke work index and left ventricular mass (LVM) are closely associated, in ESRD.

Implication for health policy/practice/research/medical education:

Several advances in dialysis therapies have been made. Still, the mortality in end-stage renal disease (ESRD) remains high at rates exceeding 15%. Cardiovascular disease from heart failure or sudden death remains an important cause for mortality in these groups. The most common cardiac anomaly in ESRD is cardiac hypertrophy and this has been observed in 75% of patients at the time of starting dialysis.

Please cite this paper as: Nazar CMJ, Bashir F, Izhar S, Ahmed SA. Does frequent hemodialysis regimen result in regression of left ventricular mass compared to conventional hemodialysis? J Nephropharmacol 2015; 4(1): 37-41.

First Name
Last Name
Email Address
Comments
Security code


Abstract View: 9259

Your browser does not support the canvas element.


PDF Download: 4156

Your browser does not support the canvas element.